facebook

What is Diabetic Maculopathy?

TL;DR: Diabetic maculopathy is damage caused by diabetes to the macula, the central part of the retina responsible for detailed vision. It often involves fluid leaking from damaged blood vessels and causing swelling, called diabetic macular oedema, which can affect reading and other close tasks. Treatment can reduce this swelling and help preserve or improve vision, particularly when it is found early, although some forms of macular damage cannot currently be reversed.

Retinopathy, damage to the blood vessels in the retina, can be widespread and quiet. Maculopathy sits where you read, and you usually notice it.

blog-image-maculopathy

How Our Medical Retina Service Works

Blue Fin Vision® provides rapid access to assessment and treatment, followed by an organised next step.

Access

Contact the clinic, and we arrange a consultant consultation and optical coherence tomography (OCT) scan, typically the same day at the nearest suitable site. OCT produces detailed cross-sectional images of the retina, the light-sensitive layer at the back of the eye.

Treatment

Where an injection is indicated, it is given at our Harley Street clinic the same day or the following day.

Continuity

Your next appointment is at four weeks, either with us or through an agreed NHS pathway.

We write to your NHS team, GP, diabetes team and optometrist so the handover is clear. If NHS treatment cannot be arranged in time, we can give the next injection.

Your Circumstances

Anti-vascular endothelial growth factor (anti-VEGF) medicines reduce leakage from retinal blood vessels. They are available on the NHS, and most people continue long-term treatment there; we often provide the first treatment and bridge to NHS care.

We also treat overseas patients and others who are not eligible for NHS-funded treatment. Medical retina consultations, OCT scans and injections are paid services.

For subsequent injections, we typically do not charge a separate consultation or OCT fee. If, at a follow-up visit, an injection is not needed, the consultation and OCT fees still apply.

Complication Readiness

We keep medication on hand to treat an acute rise in eye pressure after an injection. Every patient has the direct number of the consultant who performed their injection.

If pain, redness or worsening vision develops, even on a Sunday afternoon, you call your consultant directly rather than being sent to a general A&E department. We arrange urgent assessment, with vitreoretinal management, specialist care for the retina and the gel inside the eye, through Professor Mahmut Dogramaci where infection is suspected.

If you cannot reach your consultant promptly, do not wait: go to your nearest eye casualty or A&E department.

We plan for complications we have never had.

What Causes Diabetic Maculopathy?

  • Blurred central vision, often worse for reading.
  • Straight lines appearing distorted.
  • Colours looking washed out.

Some people have no symptoms at first, which is why screening and OCT scans matter.

If you notice changes to your vision, do not wait for your next screening appointment. Seek urgent advice for sudden worsening or blurred vision through an eye clinic, an urgent GP appointment or NHS 111. ⁸

blog-image-oct-scan-1

Diagnosis at an Eye Clinic

The NHS Diabetic Eye Screening Programme grades signs of maculopathy separately and refers people for specialist assessment. ³

At an eye clinic, OCT imaging helps assess swelling at the macula. An OCT scan measures the thickness of the macula precisely and shows exactly where fluid lies. Our article on OCT Scans explains how.

Diabetic Maculopathy Treatment

Anti-VEGF Injections

Anti-VEGF injections are the first-line treatment when swelling involves the centre of the macula and affects vision. The decision depends on your vision and the full clinical findings, not on the scan alone.

In a large comparative trial, all three medicines studied improved vision, and aflibercept gave the greatest gains when starting vision was poorer. ⁴

Laser

Laser can treat leaking areas away from the centre, and was the standard treatment before injections. ⁵

Steroid Implants

Steroid implants are an option for swelling that persists despite injections, or where injections are unsuitable.

Diabetes and Blood Pressure Control

Diabetes and blood pressure control reduce the risk of maculopathy developing and returning.

Types of Diabetic Maculopathy

  • Focal (exudative) maculopathy: leakage from particular points, often surrounded by yellow exudates.
  • Diffuse macular oedema: widespread leakage, with generalised thickening of the macula.
  • Ischaemic maculopathy: the small vessels supplying the centre of the macula close, reducing its blood supply. It causes reduced vision that treatment cannot currently reverse. It is identified with angiography, imaging that assesses the retinal blood vessels and circulation.

More than one type can be present in the same eye. ¹

Who Is at Risk?

Maculopathy becomes more likely the longer you have had diabetes and the more advanced your retinopathy. Higher blood sugar, high blood pressure, raised cholesterol and kidney disease all increase the risk.

What Injection Treatment Involves

These are intravitreal injections, meaning the medicine is delivered into the vitreous gel inside the eye.

  1. A course to start with. Injections are usually given about a month apart until the macula is dry on OCT, meaning fluid-related swelling has resolved, and vision stops improving.
  2. Extending the interval. The gap between injections is then lengthened step by step, provided the macula stays dry.
  3. Monitoring. Each visit includes a vision check and an OCT scan, which decides whether you are injected that day.

Each injection takes seconds under numbing drops. Mild grittiness, a red patch or a few floaters, small shapes drifting across your vision, are common afterwards. Serious complications such as infection are rare.

In the large comparative trial, vision improved with all three anti-VEGF medicines studied. ⁴

Steroid Implants

A small, slow-release steroid implant can be placed inside the eye when swelling persists despite injections, or when frequent injections are impractical. It can reduce swelling for several months.

Steroids can raise eye pressure and speed up cataract development, clouding of the eye’s natural lens. Eye pressure is monitored after treatment.

Maculopathy and Cataract Surgery

If you need cataract surgery, it is important that any macular swelling is controlled first, because surgery can make swelling worse in eyes with diabetic maculopathy.

Your consultant will plan the timing, and sometimes extra treatment, around your operation.

Frequently Asked Questions

Will my vision come back?

Many people gain vision with treatment, particularly if it starts before long-standing damage occurs. How much returns depends on how long the swelling has been present and whether ischaemic maculopathy is present.

Often for a year or more, with fewer injections needed over time. Some people eventually stop; others need occasional treatment long term.

Yes, where both need treatment. Each eye is prepared and treated separately.

It reduces the risk and helps treatment work, but once centre-involving swelling reduces vision, injections are usually still needed. ⁴

Why We Plan for Infection

Serious infection inside the eye, called endophthalmitis, is rare after an injection.

In a regional study in England, the risk was around 1 in 4,000 injections, similar per procedure to cataract surgery. Because far more injections were performed, they accounted for more cases; those figures describe that population, not our own patients. ⁶

Intracameral antibiotics, antibiotics delivered into the front chamber of the eye, are standard infection prevention in cataract surgery. ⁷ Anti-VEGF injections do not provide that antibiotic protection, so meticulous prevention and a clear emergency response pathway remain essential.

Mr Hove led the Eye Casualty service at the Western Eye Hospital for five years.

We have never had a case of endophthalmitis after an injection; we plan for it anyway, so that if symptoms develop, assessment and treatment are not delayed.

At Blue Fin Vision®

Diabetic macular oedema is treated under our Rapid Medical Retina Pathway, described above, with OCT imaging at every visit to guide treatment.

We write to your GP and diabetes team about blood sugar and blood pressure.

Read more about our services and the related conditions:

The Royal National Institute of Blind People (RNIB) and our patient resources provide further information:

Book a consultation with Blue Fin Vision® to discuss your diabetic maculopathy diagnosis, treatment and monitoring, with consultant-led care at clinics across London, Hertfordshire and Essex.

References

  1. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124-36.
  2. Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, et al.; Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677-82.
  3. Scanlon PH. The English National Screening Programme for diabetic retinopathy 2003-2016. Acta Diabetol. 2017;54(6):515-25.
  4. Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13):1193-203.
  5. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol. 1985;103(12):1796-806.
  6. Ong AY, Rigaudy A, Toufeeq S, Robins J, Shalchi Z, Bindra MS, et al. Intravitreal injections as a leading cause of acute postoperative endophthalmitis: a regional survey in England. Eye (Lond). 2023;37(1):163-9. doi:10.1038/s41433-021-01886-3.
  7. ESCRS Endophthalmitis Study Group. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33(6):978-88.
  8. NHS. Diabetic retinopathy [Internet]. NHS; [cited 2026 Nov 4].

ABOUT THE AUTHOR

Mr Mfazo Hove
MBChB MD FRCOphth CertLRS
Consultant Ophthalmic Surgeon | Founder and Medical Director, Blue Fin Vision®

Mr Mfazo Hove is a Consultant Ophthalmic Surgeon with more than two decades of experience across NHS and private practice and more than 57,000 ophthalmic procedures performed. He trained for six and a half years at Moorfields Eye Hospital and served for five years as an NHS consultant at the Western Eye Hospital, Imperial College Healthcare NHS Trust.

He specialises in cataract surgery, refractive lens replacement, laser vision correction and implantable Collamer lenses (ICL). He is the founder and Medical Director of Blue Fin Vision®, a private ophthalmology group providing consultant-delivered care across London, Hertfordshire and Essex. His cataract surgery outcomes are publicly reported through the National Ophthalmology Database.

A ZEISS Key Opinion Leader and international speaker, Mr Hove is a contributing author to The Ophthalmologist and Ophthalmology Times. His writing examines how clinical governance and the organisation of ophthalmic services shape patients’ experiences and outcomes, with a focus on transparent outcome reporting, surgical training and long-term accountability for patient care.

Schedule Your Consultation Today

Latest Posts